Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
CNY 65.87
(-2.18%)
CNY 65.87
(-2.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -382.77 Million CNY | -117.81% |
| 2022 | 2.14 Billion CNY | 54.11% |
| 2021 | 1.39 Billion CNY | 44.85% |
| 2020 | 963 Million CNY | 913.25% |
| 2019 | 95.04 Million CNY | 29.68% |
| 2018 | 73.29 Million CNY | 44.96% |
| 2017 | 50.56 Million CNY | 504.8% |
| 2016 | 8.35 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 197.7 Thousand CNY | 102.71% |
| 2024 Q2 | -7.29 Million CNY | -118.17% |
| 2024 Q1 | 40.14 Million CNY | 118.15% |
| 2023 FY | -382.77 Million CNY | -117.81% |
| 2023 Q1 | -18.85 Million CNY | -107.52% |
| 2023 Q2 | -48.57 Million CNY | -157.7% |
| 2023 Q4 | -221.14 Million CNY | -134.75% |
| 2023 Q3 | -94.2 Million CNY | -93.92% |
| 2022 Q4 | 250.62 Million CNY | -44.85% |
| 2022 Q3 | 454.44 Million CNY | -35.13% |
| 2022 Q2 | 700.56 Million CNY | -5.85% |
| 2022 FY | 2.14 Billion CNY | 54.11% |
| 2022 Q1 | 744.06 Million CNY | 225.78% |
| 2021 Q3 | 582.22 Million CNY | 364.69% |
| 2021 Q1 | 458.99 Million CNY | 65.3% |
| 2021 FY | 1.39 Billion CNY | 44.85% |
| 2021 Q4 | 228.39 Million CNY | -60.77% |
| 2021 Q2 | 125.29 Million CNY | -72.7% |
| 2020 Q3 | 324.17 Million CNY | 35.58% |
| 2020 Q2 | 239.1 Million CNY | 95.92% |
| 2020 Q1 | 122.04 Million CNY | 218.41% |
| 2020 FY | 963 Million CNY | 913.25% |
| 2020 Q4 | 277.67 Million CNY | -14.34% |
| 2019 FY | 95.04 Million CNY | 29.68% |
| 2019 Q4 | 38.32 Million CNY | 72.18% |
| 2019 Q3 | 22.26 Million CNY | 19.23% |
| 2019 Q1 | 15.78 Million CNY | -43.09% |
| 2019 Q2 | 18.67 Million CNY | 18.31% |
| 2018 Q4 | 27.72 Million CNY | 7.47% |
| 2018 FY | 73.29 Million CNY | 44.96% |
| 2018 Q3 | 25.8 Million CNY | 0.0% |
| 2017 FY | 50.56 Million CNY | 504.8% |
| 2016 FY | 8.35 Million CNY | 0.0% |